Eddie Hickman
Stock Analyst at Guggenheim
(1.07)
# 1518
Out of 5,297 analysts
17
Total ratings
33.33%
Success rate
20.77%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
PMN ProMIS Neurosciences | Reiterates: Buy | 6 6 | 0.69 | 769.57% | 2 | Apr 1, 2025 | |
ZVRA Zevra Therapeutics | Maintains: Strong Buy | 20 22 | 7.67 | 186.83% | 1 | Mar 13, 2025 | |
GHRS GH Research | Initiates Coverage On: Buy | 32 | 10.54 | 203.61% | 1 | Mar 13, 2025 | |
CYBN Cybin | Initiates Coverage On: Buy | 35 | 6.28 | 457.32% | 1 | Mar 13, 2025 | |
TARS Tarsus Pharmaceutica... | Maintains: Strong Buy | 75 78 | 51.6 | 51.16% | 7 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 12 12 | 1.25 | 860% | 3 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 2 | May 1, 2023 |